Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 15, Number 27, 2008

Articles

West Nile Virus NS2B/NS3 Protease As An Antiviral Target
pp. 2771-2784(14)
Authors: Chappell, K. J.; Stoermer, M. J.; Fairlie, D. P.; Young, P. R.

Favourites:
ADD

Efficacy of Chemopreventive Agents in Mouse Mammary Gland Organ Culture (MMOC) Model: A Comprehensive Review
pp. 2785-2825(41)
Authors: Mehta, Rajendra G.; Naithani, Rajesh; Huma, Loredana; Hawthorne, Michael; Moriarty, Robert M.; McCormick, David L.; Steele, Vernon E.; Kopelovich, Levy

Favourites:
ADD

Polyethylenimine In Medicinal Chemistry
pp. 2826-2839(14)
Authors: Vicennati, Paola; Giuliano, Antonella; Ortaggi, Giancarlo; Masotti, Andrea

Favourites:
ADD

The Structure and Function of Histone Deacetylases: The Target for Anti-cancer Therapy
pp. 2840-2849(10)
Authors: Zhang, Yingjie; Fang, Hao; Jiao, Jie; Xu, Wenfang

Favourites:
ADD

Aminopeptidase N (APN/CD13) as a Target for Anti-Cancer Agent Design
pp. 2850-2865(16)
Authors: Zhang, Xiaopan; Xu, Wenfang

Favourites:
ADD

Chemokine Network in the Nervous System: A New Target for Pain Relief
pp. 2866-2875(10)
Authors: Gosselin, R. D.; Dansereau, M. A.; Pohl, M.; Kitabgi, P.; Beaudet, N.; Sarret, P.; Parsadaniantz, S. M.

Favourites:
ADD

RhoA/Rho-Kinase as a Therapeutic Target in Asthma
pp. 2876-2885(10)
Author: Kume, Hiroaki

Favourites:
ADD

Recent Advances in Artemisinin Production Through Heterologous Expression
pp. 2886-2896(11)
Authors: Arsenault, Patrick R.; Wobbe, Kristin K.; Weathers, Pamela J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content